MicroRNAs in regulation of triple-negative breast cancer progression
D Piasecka, M Braun, R Kordek, R Sadej… - Journal of cancer …, 2018 - Springer
Purpose Dysregulation of miRNA profile has been associated with a broad spectrum of
cellular processes underlying progression of various human malignancies. Increasing …
cellular processes underlying progression of various human malignancies. Increasing …
MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer
L Ding, H Gu, X Xiong, H Ao, J Cao, W Lin, M Yu, J Lin… - Cells, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is the most aggressive, prevalent, and distinct subtype
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
Background Breast cancer (BC) is the most common type of cancer in women and the
second cause of cancer-related mortality world-wide. The majority of BC-related deaths is …
second cause of cancer-related mortality world-wide. The majority of BC-related deaths is …
Triple negative breast cancer in the era of miRNA
The objective of this review is to elucidate the role of miRNAs in triple negative breast cancer
(TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect …
(TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect …
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
Abstract MicroRNAs (miRNA) are 21–23 nucleotide molecules not translated into proteins
that bind and target the 3′ untranslated regions of mRNA. These characteristics make them …
that bind and target the 3′ untranslated regions of mRNA. These characteristics make them …
Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development
C Jin, B Yan, Q Lu, Y Lin, L Ma - Tumor Biology, 2016 - Springer
Recent studies demonstrated that long noncoding RNAs (lncRNAs) have a critical role in the
regulation of cancer progression and metastasis. However, little is known about the …
regulation of cancer progression and metastasis. However, little is known about the …
MIRNAS in astrocyte-derived exosomes as possible mediators of neuronal plasticity: supplementary issue: brain plasticity and repair
C Lafourcade, JP Ramírez, A Luarte… - Journal of …, 2016 - journals.sagepub.com
Astrocytes use gliotransmitters to modulate neuronal function and plasticity. However, the
role of small extracellular vesicles, called exosomes, in astrocyte-to-neuron signaling is …
role of small extracellular vesicles, called exosomes, in astrocyte-to-neuron signaling is …
[HTML][HTML] LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis
C Han, Y Fu, N Zeng, J Yin, Q Li - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
In this study, we evaluated the function and regulation of the long non-coding RNA (lncRNA)
FAM83H-AS1 in triple-negative breast cancer (TNBC). Our data show that the FAM83H-AS1 …
FAM83H-AS1 in triple-negative breast cancer (TNBC). Our data show that the FAM83H-AS1 …
The anticancer effects of flavonoids through miRNAs modulations in triple-negative breast cancer
GM Adinew, E Taka, P Mendonca, SS Messeha… - Nutrients, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) incidence rate has regularly risen over the last
decades and is expected to increase in the future. Finding novel treatment options with …
decades and is expected to increase in the future. Finding novel treatment options with …
Metadherin: a therapeutic target in multiple cancers
Altered expression of many genes and proteins is essential for cancer development and
progression. Recently, the affected expression of metadherin (MTDH), also known as AEG-1 …
progression. Recently, the affected expression of metadherin (MTDH), also known as AEG-1 …